About Rezo Therapeutics
Rezo Therapeutics is a private company based in San Francisco, California, incorporated in 2021 in Delaware. It has reported $68,066,039 raised in one offering on Form D since December 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2022 | Dec 1, 2022amended Aug 18, 2025 | $68,066,039of $80.1M target | 21 | $3.2M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rezo Therapeutics's Form D filed Aug 18, 2025.
SG
DH
Derek Hicks
Executive officer and director
NK
Nevan Krogan
Executive officer and director
TA
JC
Jennifer Chang
Secretary
GS
George Scangos
Director
NB
Norbert Bischofberger
Director
